Home Page
Multi-Site  |   RDB   |  Measurement Report   |  Software Tour   OmnipathTM |   Reimbursement  



Reimbursement for Patients Covered by Medicare

Medicare Coverage of Bone Measurement
The Bone Mass Measurement Act of 1997 standardizes Medicare coverage of medically necessary bone mass measurements by providing for uniform coverage under Medicare Part B. This standardized coverage is effective for claims with dates of service furnished on or after July 1, 1998. Measurements must be performed on a qualified individual for the purpose of identifying bone mass or detecting bone loss or determining bone quality; and includes a physician's interpretation of the results of the procedure.

Bone mass measurements are covered for patients with any one of the following indications:

  • A woman who has been determined by the physician or a qualified nonphysician
    practitioner treating her to be estrogen-deficient and at clinical risk for osteoporosis,
    based on her medical history and other findings
  • An individual with vertebral abnormalities as demonstrated by an X-ray indicating
    osteoporosis, osteopenia, or vertebral fracture
  • An individual receiving (or expecting to receive) corticosteroid therapy equivalent
    to 7.5 mg of prednisone, or greater, per day, for more than 3 months
  • An individual with primary hyperparathyroidism
  • An individual being monitored to assess response to or efficacy of an FDA-approved
    osteoporosis drug therapy

For documentation supporting the medical necessity, physicians and practitioners may use the ICD-9-CM codes that support medical necessity.

Repetitive Testing
Coverage of follow-up testing is generally limited to one measurement every two years. More frequent follow-up tests may be permitted when medically necessary. For example, more frequent testing may be permitted for an individual on long-term (more than 3 months) steroid therapy.

Medicare Reimbursement Rate by State
The national average payment by Medicare for peripheral ultrasound bone assessment is approximately $36 per study. The Medicare reimbursement rate in each state appears in the list below.

Denial of Payment
If the Medicare carrier does not pay for a bone assessment test that seems to meet the criteria for coverage, the physician's office can take the following steps:

1) Assure that the beneficiary is part of one of the five groups of individuals qualified for testing
2) Confirm that the carrier recognizes the ICD-9-CM codes used
3) Send a formal letter with additional information to the carrier to obtain coverage. Contact Sunlight Medical, Inc. for a form letter.

Often, there will be instructions regarding next steps on the denial of coverage as well. The appeals process should be utilized if an unsatisfactory decision is made by the local Medicare carrier's office.

The coding, coverage, and payment information contained herein is gathered from third party sources and is subject to change. The codes listed are possible coding options. It is always the provider's responsibility to determine and submit appropriate codes, charges, and modifiers for the services that are furnished. Providers should contact their local payers for specific information on pertinent coding, coverage and payment policies before a claim is submitted. Sunlight Medical Inc. cannot guarantee success in obtaining payments for medical services.

Click here to return to the 7000S product page